Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc is dated July 11, 2025. The document serves as a notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them, made in accordance with the UK Market Abuse Regulation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of insider trading activity and does not contain financial performance data.
Material Changes and Transaction Details
The filing details a single type of transaction executed on July 9, 2025, on the New York Stock Exchange. The transaction involved the purchase of American Depositary Shares (ADS) by senior executives as participants in the Company's Employee Stock Purchase Plan.
- Instrument: Smith & Nephew plc SPON ADR (ISIN: US83175M2052)
- Transaction Price: $29.77358 per share
- Participants and Volumes:
- Deepak Nath (Chief Executive Officer): 512.29508 shares
- Paul Connolly (President, Global Operations): 512.29508 shares
- Craig Gaffin (President, Orthopaedics): 381.29219 shares
- Mizanu Kebede (Chief Quality & Regulatory Affairs Officer): 114.62247 shares
- Scott Schaffner (President, Sports Medicine): 298.19045 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory disclosure of the aforementioned share purchases.
Key Facts for Investor Verification
- Verify the total number of shares purchased by PDMRs under the Employee Stock Purchase Plan on July 9, 2025.
- Confirm the transaction price of $29.77358 against the market price on the date of execution.
- Ensure these purchases align with the company's established insider trading policies and window periods.
- Note that this filing contains no financial performance updates or strategic changes.